BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17327605)

  • 1. Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma.
    Kleinrath T; Gassner C; Lackner P; Thurnher M; Ramoner R
    J Clin Oncol; 2007 Mar; 25(7):845-51. PubMed ID: 17327605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population.
    Nakamura E; Megumi Y; Kobayashi T; Kamoto T; Ishitoya S; Terachi T; Tachibana M; Matsushiro H; Habuchi T; Kakehi Y; Ogawa O
    Clin Cancer Res; 2002 Aug; 8(8):2620-5. PubMed ID: 12171893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes.
    Choi EH; Foster CB; Taylor JG; Erichsen HC; Chen RA; Walsh TJ; Anttila VJ; Ruutu T; Palotie A; Chanock SJ
    J Infect Dis; 2003 Apr; 187(7):1153-6. PubMed ID: 12660931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
    Romero JM; Sáenz-López P; Cózar JM; Carretero R; Canton J; Vazquez F; Concha A; Tallada M; Garrido F; Ruiz-Cabello F
    Hum Immunol; 2009 Jan; 70(1):60-4. PubMed ID: 19027043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
    Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
    Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood.
    Kabesch M; Tzotcheva I; Carr D; Höfler C; Weiland SK; Fritzsch C; von Mutius E; Martinez FD
    J Allergy Clin Immunol; 2003 Nov; 112(5):893-8. PubMed ID: 14610476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females.
    Wichukchinda N; Nakayama EE; Rojanawiwat A; Pathipvanich P; Auwanit W; Vongsheree S; Ariyoshi K; Sawanpanyalert P; Shioda T
    AIDS; 2006 Jan; 20(2):189-96. PubMed ID: 16511411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
    Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F
    Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.
    Vuoristo MS
    Cancer Genet Cytogenet; 2007 Jul; 176(1):54-7. PubMed ID: 17574964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
    Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk Chinese population.
    Wu J; Lu Y; Ding YB; Ke Q; Hu ZB; Yan ZG; Xue Y; Zhou Y; Hua ZL; Shu YQ; Liu P; Shen J; Xu YC; Shen HB
    Mol Carcinog; 2009 Jul; 48(7):626-32. PubMed ID: 19058298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
    Ezzidi I; Mtiraoui N; Kacem M; Mallat SG; Mohamed MB; Chaieb M; Mahjoub T; Almawi WY
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):401-7. PubMed ID: 18616700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma.
    Havranek E; Howell WM; Fussell HM; Whelan JA; Whelan MA; Pandha HS
    J Urol; 2005 Mar; 173(3):709-12. PubMed ID: 15711248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie.
    Negrier S; Perol D; Menetrier-Caux C; Escudier B; Pallardy M; Ravaud A; Douillard JY; Chevreau C; Lasset C; Blay JY;
    J Clin Oncol; 2004 Jun; 22(12):2371-8. PubMed ID: 15197198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
    Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
    Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
    Riemann K; Struwe H; Eisenhardt A; Obermaier B; Schmid KW; Siffert W
    Pharmacogenet Genomics; 2008 Nov; 18(11):999-1008. PubMed ID: 18815590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype-tagging interleukin-10 promoter polymorphism is associated with reduced risk of retinal artery occlusion.
    Weger M; Steinbrugger I; El-Shabrawi Y; Wegscheider BJ; Weger W; Renner W; Schmut O; Haas A
    Mol Vis; 2007 Apr; 13():549-52. PubMed ID: 17438520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
    Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC
    Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL4-589C/T polymorphism and IgE levels in severe malaria.
    Verra F; Luoni G; Calissano C; Troye-Blomberg M; Perlmann P; Perlmann H; Arcà B; Sirima BS; Konaté A; Coluzzi M; Kwiatkowski D; Modiano D
    Acta Trop; 2004 Apr; 90(2):205-9. PubMed ID: 15177147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.